Grant: Discovery Grants Program - Individual
McMaster University
$62,000.00
Low-Cost Biosensors for Rapid and Specific Detection of Targets in Complex Samples
FY 2024-25
Summary
Overview: We aim to develop easy-to-use, low-cost sensors (under $1) for diverse applications, including rapid disease testing, water, and food safety. These sensors exploit the unique properties of functional nucleic acids (FNAs), which are DNA molecules capable of specifically binding to a target (aptamers) or catalyzing a cleavage reaction (RNA-cleaving DNAzymes). In the past, we have made significant progress in using FNAs to create sensors to detect pathogens (Legionella and Salmonella). The sensors do not need lab-based equipment for use. Through this grant, we will work to enhance the sensors' sensitivity, especially when analyzing complex samples (such as human fecal samples), make these sensors as user-friendly as pH paper and integrate these findings into practical applications.
Importance to Whom and Why: Rapid testing is crucial for global health, a lesson underscored during the COVID-19 pandemic. Sensors are pivotal in ensuring safe water, food, and facilitating routine clinical tests. Our research targets low-resource settings. Empowering people to monitor their health, food, and water quality aligns with Canada's social values, promoting equity in healthcare.
Anticipated Outcomes: We propose to enhance FNA-based sensors' ability to detect targets of interest present at low concentrations by integrating FNAs with powerful and robust methods for signal amplification, such as the isothermal DNA amplification process called recombinase polymerase amplification (RPA). We have selected pathogens of interest (Legionella, Salmonella, H. pylori, C. difficile, and SARS-CoV-2) as model targets to explore these new methods. The effectiveness of the detection methods will be tested in water, food, urine, and fecal samples.
Benefits to Research Field and Canada: We expect this work to generate several benefits:
1.Scientific Advancement: Push the boundaries of biosensor technology, enhancing scientific knowledge in the field of functional nucleic acids, and isothermal amplification methods.
2.Empower Healthcare: Enabling affordable, accessible, and rapid testing methods that can transform healthcare outcomes, especially in low-resource communities.
3.Economic Growth: Facilitating technology transfer to the private sector, leading to patents and commercial products, thereby boosting Canada's biotechnology sector.
4.Train Future Leaders: Providing training opportunities for the next generation of scientists and engineers, fostering innovation and leadership in academia, industry, and NGOs.
In summary, this research program addresses critical global health challenges, emphasizing affordable and accessible sensors. By combining cutting-edge scientific techniques with practical applications, this work advances the research field and promises significant societal impact, aligning with Canada's commitment to social equity and innovation.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2024-05650
Name nom
Filipe, Carlos
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
62000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Low-Cost Biosensors for Rapid and Specific Detection of Targets in Complex Samples
Keywords
point-of-use; equipment-free; extraction; amplification; detection; aptamers; dnazyme; proteins; enzymes; low-cost
Application summary
Overview: We aim to develop easy-to-use, low-cost sensors (under $1) for diverse applications, including rapid disease testing, water, and food safety. These sensors exploit the unique properties of functional nucleic acids (FNAs), which are DNA molecules capable of specifically binding to a target (aptamers) or catalyzing a cleavage reaction (RNA-cleaving DNAzymes). In the past, we have made significant progress in using FNAs to create sensors to detect pathogens (Legionella and Salmonella). The sensors do not need lab-based equipment for use. Through this grant, we will work to enhance the sensors' sensitivity, especially when analyzing complex samples (such as human fecal samples), make these sensors as user-friendly as pH paper and integrate these findings into practical applications.
Importance to Whom and Why: Rapid testing is crucial for global health, a lesson underscored during the COVID-19 pandemic. Sensors are pivotal in ensuring safe water, food, and facilitating routine clinical tests. Our research targets low-resource settings. Empowering people to monitor their health, food, and water quality aligns with Canada's social values, promoting equity in healthcare.
Anticipated Outcomes: We propose to enhance FNA-based sensors' ability to detect targets of interest present at low concentrations by integrating FNAs with powerful and robust methods for signal amplification, such as the isothermal DNA amplification process called recombinase polymerase amplification (RPA). We have selected pathogens of interest (Legionella, Salmonella, H. pylori, C. difficile, and SARS-CoV-2) as model targets to explore these new methods. The effectiveness of the detection methods will be tested in water, food, urine, and fecal samples.
Benefits to Research Field and Canada: We expect this work to generate several benefits:
1.Scientific Advancement: Push the boundaries of biosensor technology, enhancing scientific knowledge in the field of functional nucleic acids, and isothermal amplification methods.
2.Empower Healthcare: Enabling affordable, accessible, and rapid testing methods that can transform healthcare outcomes, especially in low-resource communities.
3.Economic Growth: Facilitating technology transfer to the private sector, leading to patents and commercial products, thereby boosting Canada's biotechnology sector.
4.Train Future Leaders: Providing training opportunities for the next generation of scientists and engineers, fostering innovation and leadership in academia, industry, and NGOs.
In summary, this research program addresses critical global health challenges, emphasizing affordable and accessible sensors. By combining cutting-edge scientific techniques with practical applications, this work advances the research field and promises significant societal impact, aligning with Canada's commitment to social equity and innovation.